These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3902026)

  • 21. Studies on the mechanisms of the radiosensitizing and cytotoxic properties of RSU-1069 and its analogues.
    Walling JM; Stratford IJ; Adams GE; Silver AR; Ahmed I; Jenkins TC; Fielden EM
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1083-6. PubMed ID: 3755712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative DNA damage and repair induced by misonidazole, CB 1954 and RSU 1069.
    Dale LD; Widdick DA; Edwards DI; Biol GI
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):995-9. PubMed ID: 2649469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analogues of RSU-1069: radiosensitization and toxicity in vitro and in vivo.
    Ahmed I; Jenkins TC; Walling JM; Stratford IJ; Sheldon PW; Adams GE; Fielden EM
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1079-81. PubMed ID: 3755711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual-function radiation sensitizers and bioreductive drugs: factors affecting cellular uptake and sensitizing efficiency in analogues of RSU 1069.
    Walling J; Stratford IJ; Adams GE; Stephens MA
    Int J Radiat Biol Relat Stud Phys Chem Med; 1988 Apr; 53(4):641-9. PubMed ID: 3258298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the toxicity of RSU-1069.
    Whitmore GF; Gulyas S
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1219-22. PubMed ID: 3755716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacology of the mixed-function radio- and chemosensitizers CB 1954 and RSU 1069.
    Workman P; Walton MI
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1307-10. PubMed ID: 6547936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variation of the radiosensitizing efficiency of RSU-1069 with pre-irradiation contact times: a rapid mix study.
    Austen KR; Jenner TJ; O'Neill P; Fielden EM
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Aug; 52(2):281-8. PubMed ID: 3497125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic contribution to the improved therapeutic selectivity of a novel bromoethylamino prodrug (RB 6145) of the mixed-function hypoxic cell sensitizer/cytotoxin alpha-(1-aziridinomethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069).
    Binger M; Workman P
    Cancer Chemother Pharmacol; 1991; 29(1):37-47. PubMed ID: 1742848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental pharmacokinetics of RSU-1069 and its analogues: high tumor/plasma ratios.
    Deacon JM; Holliday SB; Ahmed I; Jenkins TC
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1087-90. PubMed ID: 3755713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The chemosensitizing and cytotoxic effects of RSU 1164 and RSU 1165 in a murine tumor model.
    Siemann DW
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1115-8. PubMed ID: 2703392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inactivation and repair of double-stranded DNA damaged by the aziridinyl nitroimidazole RSU 1069.
    Lafleur MV; Westmijze EJ; Visser OJ; Wagenaar N; Soetekouw R; Loman H; Retel J
    Chem Biol Interact; 1992 Mar; 82(1):55-71. PubMed ID: 1532139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RSU 1069, a 2-nitroimidazole containing an alkylating group: high efficiency as a radio- and chemosensitizer in vitro and in vivo.
    Adams GE; Ahmed I; Sheldon PW; Stratford IJ
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1653-6. PubMed ID: 6548211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxygen transfer from the nitro group of a nitroaromatic radiosensitizer to a DNA sugar damage product.
    Kappen LS; Lee TR; Yang CC; Goldberg IH
    Biochemistry; 1989 May; 28(11):4540-2. PubMed ID: 2527556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies with bifunctional bioreductive drugs. II. Cytotoxicity assayed with A-549 lung carcinoma cells of human origin.
    Roizin-Towle L; Pirro JP; Hall EJ
    Radiat Res; 1990 Oct; 124(1 Suppl):S50-5. PubMed ID: 2236511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new class of analogues of the bifunctional radiosensitizer alpha-(1-aziridinylmethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069): the cycloalkylaziridines.
    Suto MJ; Stier MA; Werbel LM; Arundel-Suto CM; Leopold WR; Elliott WE; Sebolt-Leopold JS
    J Med Chem; 1991 Aug; 34(8):2484-8. PubMed ID: 1875345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacologic/pharmacokinetic evaluation of emesis induced by analogs of RSU 1069 and its control by antiemetic agents.
    Sebolt-Leopold JS; Vincent PW; Beningo KA; Elliott WL; Leopold WR; Heffner TG; Wiley JN; Stier MA; Suto MJ
    Int J Radiat Oncol Biol Phys; 1992; 22(3):549-51. PubMed ID: 1531213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High uptake of RSU 1069 and its analogues melanotic melanomas.
    Walling JM; Deacon J; Holliday S; Stratford IJ
    Cancer Chemother Pharmacol; 1989; 24(1):28-32. PubMed ID: 2541936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of nitroreduction products of misonidazole to nucleic acids and protein.
    Varghese AJ; Whitmore GF
    Cancer Clin Trials; 1980; 3(1):43-6. PubMed ID: 7389036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies with bifunctional bioreductive drugs. I. In vitro oncogenic transforming potential.
    Hei TK; He ZY; Piao CQ; Hall EJ
    Radiat Res; 1990 Oct; 124(1 Suppl):S44-9. PubMed ID: 2236509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic enhancement of the efficacy of the bioreductively activated alkylating agent RSU-1164 in the treatment of prostatic cancer by photodynamic therapy.
    Henry JM; Isaacs JT
    J Urol; 1989 Jul; 142(1):165-70. PubMed ID: 2733098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.